Showing results (141-150 of 1,687) with videos related to

Sort By:
Pageof 169
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Determinants of rapamycin sensitivity in breast cancer cellsWoo-Chul Noh, Wallace H Mondesire, Junying Peng, et al.
Oncotarget|September 7, 2019
TAK228 enhances antitumor activity of eribulin in triple negative breast cancerNicci Owusu-Brackett, Kurt W Evans, Argun Akcakanat, et al.
Cancer|July 30, 2011
Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancerSoley Bayraktar, Leonel F Hernadez-Aya, Xiudong Lei, et al.
JCO Clinical Cancer Informatics|September 25, 2019
Operationalization of Next-Generation Sequencing and Decision Support for Precision OncologyJia Zeng, Amber Johnson, Md Abu Shufean, et al.
Breast Cancer Research and Treatment|July 30, 2008
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrowAnthony Lucci, Savitri Krishnamurthy, Balraj Singh, et al.
The Breast Journal|September 9, 2009
False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burdenRegina M Fearmonti, Larissa I Batista, Funda Meric-Bernstam, et al.
Journal of Hematology & Oncology|August 3, 2014
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trialVivek Subbiah, Funda Meric-Bernstam, Gordon B Mills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2019
A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene AlterationsMartin H Voss, Cinta Hierro, Rebecca S Heist, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Building a predictive breast cancer risk modelConstance M Johnson, Joe Ensor, Kristine Broglio, et al.
Annals of Surgical Oncology|November 10, 2010
Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancerAbigail S Caudle, Ana M Gonzalez-Angulo, Kelly K Hunt, et al.
Pageof 169